"Polydeoxyribonucleotides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of 13 or more deoxyribonucleotides in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.
Descriptor ID |
D011089
|
MeSH Number(s) |
D13.695.578.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Polydeoxyribonucleotides".
Below are MeSH descriptors whose meaning is more specific than "Polydeoxyribonucleotides".
This graph shows the total number of publications written about "Polydeoxyribonucleotides" by people in this website by year, and whether "Polydeoxyribonucleotides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2017 | 3 | 0 | 3 |
2018 | 6 | 0 | 6 |
2019 | 3 | 0 | 3 |
2020 | 1 | 2 | 3 |
2021 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Polydeoxyribonucleotides" by people in Profiles.
-
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide. JCI Insight. 2021 09 08; 6(17).
-
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes. Expert Opin Ther Targets. 2021 06; 25(6):423-433.
-
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. Br J Haematol. 2021 04; 193(1):43-51.
-
Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection. Transplantation. 2021 02 01; 105(2):e22-e24.
-
Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):622-625.
-
Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders? J Thromb Haemost. 2020 Nov; 18(11):3106-3108.
-
Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?" J Thromb Haemost. 2020 11; 18(11):3111-3113.
-
Defibrotide in the COVID-19 coagulopathy: What is the timing? J Thromb Haemost. 2020 11; 18(11):3113-3115.
-
Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study. Minerva Med. 2020 08; 111(4):366-368.
-
Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide. Front Immunol. 2019; 10:2339.